PGE1 Improves Coronary Microcirculation Dysfunction in Patients With CAD and Diabetes
NCT03159559
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Coronary Microvascular Perfusion in Patients With Ischemic Heart Disease
Interventions
DRUG:
Lipo-PGE1
Sponsor
Tongji Hospital